Human Concentrative Nucleoside Transporter 3 Transfection with Ultrasound and Microbubbles in Nucleoside Transport Deficient HEK293 Cells Greatly Increases Gemcitabine Uptake

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Paproski, Robert J ^a   Yao, Sylvia Y M ^a   Favis, Nicole ^a   Evans, David ^a   Young, James D ^a   Cass, Carol E ^a   Zemp, Roger J ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; DILAZEP; GEMCITABINE; HUMAN CONCENTRATIVE NUCLEOSIDE TRANSPORTER 3; MESSENGER RNA; NUCLEOSIDE TRANSPORTER; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CELL STRAIN HEK293; CHANNEL GATING; CONCENTRATIVE NUCLEOSIDE TRANSPORTER 3 GENE; DRUG SENSITIVITY; DRUG UPTAKE; EMBRYO; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MICROBUBBLE; MOUSE; NONHUMAN; NUCLEOSIDE TRANSPORT; OOCYTE TRANSPORT; PANCREAS CANCER; REPORTER GENE; TUMOR GENE; TUMOR XENOGRAFT; ULTRASOUND;

ANIMALS; BIOLOGICAL TRANSPORT; CELL SURVIVAL; DEOXYCYTIDINE; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 1; GENE EXPRESSION; HEK293 CELLS; HUMANS; MEMBRANE TRANSPORT PROTEINS; MICE; MICROBUBBLES; OOCYTES; TRANSFECTION; XENOPUS LAEVIS;

EID: 84874184800     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0056423     Document Type: Article

References (33)

1. Toschi L, Finocchiaro G, Bartolini S, Gioia V, Cappuzzo F, (2005) Role of gemcitabine in cancer therapy. Future Oncol 1: 7-17.
2. Mackey JR, Mani RS, Selner M, Mowles D, Young JD, et al. (1998) Functional nucleoside transporters are required for gemcitabine influx and manifestation of toxicity in cancer cell lines. Cancer Res 58: 4349-4357.
3. Baldwin SA, Beal PR, Yao SY, King AE, Cass CE, et al. (2004) The equilibrative nucleoside transporter family, SLC29. Pflugers Arch 447: 735-743.
4. Gray JH, Owen RP, Giacomini KM, (2004) The concentrative nucleoside transporter family, SLC28. Pflugers Arch 447: 728-734.
5. Damaraju VL, Mowles D, Yao S, Ng A, Young JD, et al. (2012) Role of human nucleoside transporters in the uptake and cytotoxicity of azacitidine and decitabine. Nucleosides Nucleotides Nucleic Acids 31: 236-255.
6. Farrell JJ, Elsaleh H, Garcia M, Lai R, Ammar A, et al. (2009) Human equilibrative nucleoside transporter 1 levels predict response to gemcitabine in patients with pancreatic cancer. Gastroenterology 136: 187-195.
7. Giovannetti E, Del Tacca M, Mey V, Funel N, Nannizzi S, et al. (2006) Transcription analysis of human equilibrative nucleoside transporter-1 predicts survival in pancreas cancer patients treated with gemcitabine. Cancer Res 66: 3928-3935.
8. Marechal R, Mackey JR, Lai R, Demetter P, Peeters M, et al. (2009) Human equilibrative nucleoside transporter 1 and human concentrative nucleoside transporter 3 predict survival after adjuvant gemcitabine therapy in resected pancreatic adenocarcinoma. Clin Cancer Res 15: 2913-2919.
9. Michalski CW, Erkan M, Sauliunaite D, Giese T, Stratmann R, et al. (2008) Ex vivo chemosensitivity testing and gene expression profiling predict response towards adjuvant gemcitabine treatment in pancreatic cancer. Br J Cancer 99: 760-767.
10. Spratlin J, Sangha R, Glubrecht D, Dabbagh L, Young JD, et al. (2004) The absence of human equilibrative nucleoside transporter 1 is associated with reduced survival in patients with gemcitabine-treated pancreas adenocarcinoma. Clin Cancer Res 10: 6956-6961.
11. Perez-Torras S, Garcia-Manteiga J, Mercade E, Casado FJ, Carbo N, et al. (2008) Adenoviral-mediated overexpression of human equilibrative nucleoside transporter 1 (hENT1) enhances gemcitabine response in human pancreatic cancer. Biochem Pharmacol 76: 322-329.
12. Veltkamp SA, Pluim D, van Eijndhoven MA, Bolijn MJ, Ong FH, et al. (2008) New insights into the pharmacology and cytotoxicity of gemcitabine and 2′,2′-difluorodeoxyuridine. Mol Cancer Ther 7: 2415-2425.
13. Lang TT, Selner M, Young JD, Cass CE, (2001) Acquisition of human concentrative nucleoside transporter 2 (hcnt2) activity by gene transfer confers sensitivity to fluoropyrimidine nucleosides in drug-resistant leukemia cells. Mol Pharmacol 60: 1143-1152.
14. Lang TT, Young JD, Cass CE, (2004) Interactions of nucleoside analogs, caffeine, and nicotine with human concentrative nucleoside transporters 1 and 2 stably produced in a transport-defective human cell line. Mol Pharmacol 65: 925-933.
15. Hernot S, Klibanov AL, (2008) Microbubbles in ultrasound-triggered drug and gene delivery. Adv Drug Deliv Rev 60: 1153-1166.
16. Chen S, Ding JH, Bekeredjian R, Yang BZ, Shohet RV, et al. (2006) Efficient gene delivery to pancreatic islets with ultrasonic microbubble destruction technology. Proc Natl Acad Sci U S A 103: 8469-8474.
17. Luo YK, Zhao YZ, Lu CT, Tang J, Li XK, (2008) Application of ultrasonic gas-filled liposomes in enhancing transfer for breast cancer-related antisense oligonucleotides: an experimental study. J Liposome Res 18: 341-351.
18. Paproski RJ, Ng AM, Yao SY, Graham K, Young JD, et al. (2008) The role of human nucleoside transporters in uptake of 3′-deoxy-3′-fluorothymidine. Mol Pharmacol 74: 1372-1380.
19. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
20. Cass CE, Young JD, Baldwin SA, (1998) Recent advances in the molecular biology of nucleoside transporters of mammalian cells. Biochem Cell Biol 76: 761-770.
21. Li YS, Davidson E, Reid CN, McHale AP, (2009) Optimising ultrasound-mediated gene transfer (sonoporation) in vitro and prolonged expression of a transgene in vivo: potential applications for gene therapy of cancer. Cancer Lett 273: 62-69.
22. Rahim AA, Taylor SL, Bush NL, ter Haar GR, Bamber JC, et al. (2006) Spatial and acoustic pressure dependence of microbubble-mediated gene delivery targeted using focused ultrasound. J Gene Med 8: 1347-1357.
23. Tlaxca JL, Anderson CR, Klibanov AL, Lowrey B, Hossack JA, et al. (2010) Analysis of in vitro transfection by sonoporation using cationic and neutral microbubbles. Ultrasound Med Biol 36: 1907-1918.
24. Qiu Y, Luo Y, Zhang Y, Cui W, Zhang D, et al. (2010) The correlation between acoustic cavitation and sonoporation involved in ultrasound-mediated DNA transfection with polyethylenimine (PEI) in vitro. J Control Release 145: 40-48.
25. Deshpande MC, Prausnitz MR, (2007) Synergistic effect of ultrasound and PEI on DNA transfection in vitro. J Control Release 118: 126-135.
26. Tsunoda S, Mazda O, Oda Y, Iida Y, Akabame S, et al. (2005) Sonoporation using microbubble BR14 promotes pDNA/siRNA transduction to murine heart. Biochem Biophys Res Commun 336: 118-127.
27. Sheeran PS, Luois S, Dayton PA, Matsunaga TO, (2011) Formulation and acoustic studies of a new phase-shift agent for diagnostic and therapeutic ultrasound. Langmuir 27: 10412-10420.
28. Paproski R, Young J, Cass C, (2010) Predicting gemcitabine transport and toxicity in human pancreatic cancer cell lines with the positron emission tomography tracer 3′-deoxy-3′-fluorothymidine. Biochem Pharmacol 79: 587-595.
29. Butterweck A, Gergs U, Elfgang C, Willecke K, Traub O, (1994) Immunochemical characterization of the gap junction protein connexin45 in mouse kidney and transfected human HeLa cells. J Membr Biol 141: 247-256.
30. Del Re AM, Woodward JJ, (2005) Inhibition of gap junction currents by the abused solvent toluene. Drug Alcohol Depend 78: 221-224.
31. Pant S, Hilton H, Burczynski ME, (2012) The multifaceted exosome: biogenesis, role in normal and aberrant cellular function, and frontiers for pharmacological and biomarker opportunities. Biochem Pharmacol 83: 1484-1494.
32. Sokolova V, Ludwig AK, Hornung S, Rotan O, Horn PA, et al. (2011) Characterisation of exosomes derived from human cells by nanoparticle tracking analysis and scanning electron microscopy. Colloids Surf B Biointerfaces 87: 146-150.
33. Pennycooke M, Chaudary N, Shuralyova I, Zhang Y, Coe IR, (2001) Differential expression of human nucleoside transporters in normal and tumor tissue. Biochem Biophys Res Commun 280: 951-959.